-
Signature
-
By: /s/ Kathleen A. McGowan For: Matthew E. Korenberg
-
Stock symbol
-
PVLA
-
Transactions as of
-
Feb 5, 2025
-
Transactions value $
-
$0
-
Form type
-
4/A - Amendment
-
Date filed
-
2/10/2025, 05:21 PM
-
Date Of Original Report
-
Feb 7, 2025
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PVLA |
Incentive Stock Option (right to buy) |
Award |
$0 |
+5.37K |
|
$0.00 |
5.37K |
Feb 5, 2025 |
Common Stock |
5.37K |
$14.76 |
Direct |
F1 |
| transaction |
PVLA |
Non-Qualified Stock Option (right to buy) |
Award |
$0 |
+124K |
|
$0.00 |
124K |
Feb 5, 2025 |
Common Stock |
124K |
$14.76 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
This amendment is being filed to reflect a change in the reporting person's name from Palvella Therapeutics, Inc to Matthew E. Korenberg.